Completed

Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Acid-Base Imbalance+25

+ Acidosis

+ Brain Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: December 1978
See protocol details

Summary

Principal SponsorNational Center for Research Resources (NCRR)
Last updated: July 10, 2008
Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 1978

Actual date on which the first participant was enrolled.

PROTOCOL OUTLINE: Patients fast for 6 hours. Glucagon IM is administered after the 6 hour fast. Glucose level is measured at 0, 15, 30, 45, 60, and 90 minutes. In children of sufficient size, alanine and lactic acid should also be measured at each or most of these time points. Fasting continues for at least 18 hours. Glucagon IM is administered again at end of fast. Glucose level is measured at time 0, 15, 30, 45, 60, and 90 minutes.

NCT00004353
Principal SponsorNational Center for Research Resources (NCRR)
Last updated: July 10, 2008
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

35 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Acid-Base ImbalanceAcidosisBrain DiseasesBrain Diseases, MetabolicCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersMetabolic DiseasesMuscular DiseasesMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System DiseasesNeuromuscular DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesMitochondrial EncephalomyopathiesBrain Diseases, Metabolic, InbornDisease AttributesMitochondrial DiseasesGenetic Diseases, InbornCerebral Small Vessel DiseasesAcidosis, LacticMetabolism, Inborn ErrorsMitochondrial MyopathiesMELAS SyndromeRare Diseases

Criteria

PROTOCOL ENTRY CRITERIA: Diagnostically documented elevation in lactate, pyruvate, and/or alanine levels in lactic acidemia patients

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

University of California San Diego Medical Center

San Diego, United StatesOpen University of California San Diego Medical Center in Google Maps
CompletedOne Study Center